Metabolically active coronary microvessels (generally < 100 fim in diameter) were isolated from bovine hearts. These preparations were virtually free of contaminating myocytes and consisted of a mixture of arterioles, venules, capillaries, and collagen fibers. The prostaglandin biosynthetic capacity of isolated coronary micro vessels was assessed by quantitating conversion of "C-arachidonic acid and '"C-prostaglandin endoperoxide (PGH») to prostaglandins. Coronary microvessels were found to exhibit low cyclooxygenase activity, i.e., minimal conversion (<1%) of arachidonic acid (AA) to prostagtandins when compared with either the coronary artery (3.6% conversion of AA) or coronary vein (3.3%). Isolated myofibril fractions demonstrated virtually no cyclooxygenase activity (<0.1%). Two enzymatic endoperoxide metabolizing activities were evident in the microvessels, prostacyclin synthetase and PGE isomerase. When compared on a microsomal protein basis, the coronary artery exhibited higher prostacyclin synthetase activity than the microvessels but wag devoid of PGE isomerase activity. In contrast, whereas PGE isomerase activity was detectable in the coronary vein, the activity was lower than that of the micro vessels; further, it could not be demonstrated in the other myocardial fractions. A glutathione-enhanced PGD-forming activity was present in high speed supernatant* derived from the coronary artery and vein preparations, but was not present in the coronary microvessel or isolated myofibril fractions. From these studies we conclude that (1) the major source of prostaglandins released into the coronary circulation is the coronary vasculature, and (2) the resistance elements of the coronary circulation differ from the larger elements (Le., arteries and veins) in the enzyme* of the prostaglandin biosynthetic pathway present and thus in the nature and perhaps quantity of prostaglandins biosynthesized.
STUDIES of the metabolic conversion of arachidonic acid to prostaglandin products by mammalian myocardium have been reported from several laboratories utilizing different experimental procedures. Isakson et al. (1977) found that the major product released from rabbit hearts prelabeled with exogenous [l-M C]-arachidonic acid was a novel prostaglandin product subsequently identified as 6keto-PGFi 0 , the degradative product of prostacyclin (PGI 2 ). Needleman et al. (1978) and Schror et al. (1978) reported that PGEz, PGD 2 , and 6-keto-PGFi a were released from isolated perfused rabbit or guinea pig myocardium. Isolated bovine coronary arteries were reported (Raz et al., 1977b) to release primarily 6-keto-PGF ]o . Hseuh and Needleman (1978) and Needleman et al. (1978) , utilizing differential labeling with [ u C]-arachidonic acid, indicated that myocytes may not possess prostaglandin biosynthetic activity and that the predominant site of prostaglandin synthesis was localized to the coronary vasculature. However, more definitive localization of the prostaglandin biosynthetic pathway in the mammalian myocardium has received limited investigation.
The prostaglandin biosynthetic pathway consists of three components: (1) acylhydrolase that liberates arachidonate from membrane phospholipids, -2) cyclooxygenase activity which synthesizes endoperoxides, and (3) prostaglandin endoperoxide metabolizing activities (i.e., PGE-isomerase, PGDisomerase, prostacyclin synthetase, thromboxane synthetase). The type of prostaglandin or prostanoid formed is determined by the activities of the endoperoxide-metabolizing enzymes present and expressed, whereas the quantity of product is governed largely by the first two steps of the pathway. Our experimental approach is to examine systematically each of these steps to develop a more complete definition of this pathway. To facilitate this approach in the mammalian heart, we developed a procedure for the isolation of metabolically active bovine coronary microvessels. Using this preparation, we have examined the nature of the prostaglandin-synthesizing activities (i.e., cyclooxygenase and prostaglandin endoperoxide metabolizing enzymes) in this and four other fractions prepared from the bovine heart: whole myocardium, coronary artery, coronary vein, and isolated myofibrils.
Methods

Isolation of Microvessels and Myoflbrils
Hearts from freshly killed cattle were immediately placed in ice and transported back to the laboratory for further dissection and isolation. All subsequent steps were performed at 4°C unless otherwise indicated. Pieces of ventricular wall were removed, trimmed of fat, large coronary vessels, and superficial connective tissues and thus constitute the "myocardium" fraction. The "coronary artery" fraction was composed of the circumflex and left anterior descending artery dissected free of fat and connective tissue. The great coronary vein, dissected free of adhering tissues, was termed the "coronary vein" fraction.
Coronary microvessels were obtained free of both large arteries and veins and also of myoflbrils by a series of steps involving sequential dissection, homogenization, sieving, and glass bead purification. The left and right ventricles were dissected free of adhering fat, connective tissue, valves, and large coronary arteries and veins. The exterior and interior surfaces of the heart were removed with a sharp scalpel and the remaining ventricular wall was cut into small pieces with scissors and minced finely in a meat grinder, followed by a 1:3 dilution in Krebs-Henseleit buffer (pH 7.4) containing 0.1% bovine serum albumin. The resulting suspension was then subjected to four 5-second homogenizations at maximum speed, using a Sorvall Omnimixer. The homogenate was poured over a 120-/*m nylon mesh sieve (Tetko) and the sieve was washed extensively. The tissue elements adhering to the sieve were a reddish brown color and of a stringy consistency. This material was removed from the sieve, diluted with buffer, and rehomogenized as described above, followed by a repetition of the sieving step using a clean sieve. The consistency of the material following this second sieving was relatively fibrous, and of a light brown color. Phase contrast microscopy disclosed a suspension of myocytes, small branching vessels, and collagen fibers. The suspension was then gently homogenized with an all-glass homogenizer (Kontes, Dounce, 40 ml capacity), care being taken not to grind the tissue but rather to "free" the myocytes from the vessel network. If the suspensions were ground harshly at this step, loss in endothelial cells occurred, resulting in a preparation rich in collagen fibrils with relatively few intact microvessels.
The resulting homogenate was poured through a 10 X 5 cm column of glass beads (2-3 mm diameter, Corning) followed by extensive washing with buffer. This step resulted in a very efficient removal of the myofibrils (which pass through the column) from the microvessels (which adhere to the surface of the beads). We removed the microvessels from the glass beads by pouring the column into a large volume of buffer and stirring briskly with a glass stirring rod; microvessels floated to the surface and were removed by decanting the buffer. This stirdecant procedure was repeated 3-4 times. Further purification was then achieved by repeating the Dounce homogenization-glass bead step until the preparation was virtually free of myofibrils. The resulting microvessel suspension was then poured through a 25-/un nylon mesh sieve, the filtrate discarded, and the microvessels isolated mechanically from the sieve. Yield of microvessels from minced bovine heart ranged from 0.3 to 1.5% (wet weight).
The microvessels derived by this procedure were resuspended in buffer and tested for oxidative metabolism, using H C-glutamate as substrate, after the methods of Brendel et al. (1974) . Evolution of H C-CO 2 was linear over the period of study (2 hours). Similar results were observed with lJ| C-glucose.
The appearance of a typical preparation of intact microvessels when examined with phase contrast microscopy is shown in Figure 1 and in thin section stained with hematoxylin and eosin in Figure 2 . The preparations characteristically appeared as a multibranched network of small arterioles, capillaries, and venules surrounded by collagen fibers. The diameters of the vessels generally ranged from 7-80 inn, with the majority in the 7-20 /im range.
After the initial sieving step in the microvessel isolation procedure, a preparation of isolated myofibrils generally free of vascular elements was obtained. This fraction was further homogenized, clarified by passage through an 89-/im mesh nylon sieve and the resulting filtrate used as the "isolated myofibril" preparation for the biochemical studies indicated below. All tissue components were frozen in liquid N2 after isolation and stored at -70°C until used for assay.
Preparation of Homogenates and Microsomes
Frozen tissue preparations (myocardium, coronary artery, coronary vein, isolated myofibrils, and isolated coronary microvessels) were freeze-powdered at liquid N 2 temperature with a stainless steel press. Three volumes of potassium phosphate buffer (50 min), pH 7.4, containing 1 miK ethylenediaminetetraacetic acid (EDTA) were added and the suspension sonicated (Branson sonifier, taper tip). Initial homogenates of these five tissues were then centrifuged at 10,000 g for 20 minutes and the resulting supernatant decanted through glass wool (this fraction is termed the homogenate). Microsomes then were prepared from the various homogenate fractions by a further centrifugation at 105,000 g for 1 hour and the microsomal pellets were suspended in the phosphate-EDTA buffer by a brief sonication. The supernatant from the high speed centrifugation was also retained for analysis and termed the high speed supernatant. All fractions were snap frozen and stored at -70°C in 200- VOL. 49, No. 5, NOVEMBER 1981 FIGURE /J aliquots. Protein concentrations were determined by a modification of the Lowry method (Markwell, et al., 1978) using bovine serum albumin (Pentex) as the standard.
Radiometric Microassay
The radiometric assay used in the present study was similar to that originally described by Skidgel and Printz (1978) . The primary modification involved changes in the handling procedure to minimize degradation of unreacted endoperoxide PGH 2 ). [1-14 C]-PGH 2 was prepared from [1-14 C]arachidonic acid, using ram seminal vesicle microsomes as a source of cyclooxygenase as previously detailed. In this procedure, 0.2 nmol (25,000 dpm) prostaglandin endoperoxide ([1-M C]PGH 2 ) was pipetted into cold (0°C) 1.5-ml centrifuge tubes (Brinkman) and the ethereal solution evaporated to dryness with dry nitrogen. During this procedure, aliquots of homogenate, high speed supernatant, or microsome suspensions were diluted to 125 /il with the appropriate volume of phosphate-EDTA buffer (with or without sulfhydryl reagents), and pre-incubated 5 minutes at 23°C. To initiate the reaction, a magnetic flea was added to the evaporated endoperoxide, the tube placed on a magnetic stirrer, and a 100-^1 aliquot of the diluted tissue preparation added with rapid stirring. Control experiments substituted equal volumes of phosphate buffer, bovine serum albumin, or heat-denatured microvessel microsomes for the diluted tissue solutions. Products of the endoperoxide reaction were extracted by the addition to the incubation tube of 350 /d of extraction solvent (ethyl acetate :methanol: 0.2 M citric acid, 15:2:1, vol/vol/vol), followed by a brief centrifugation at 12,800 g for 30 seconds to resolve organic and aqueous phases. The tubes then were immediately placed in an acetone-dry ice bath which quickly froze the aqueous layer and facilitated removal of the organic phase. The entire organic layer then was applied to prescored silica gel thin layer plates (20 x 20 cm) (Analtech, GHL) using an automatic spotting device (Kontes). Authentic PG standards also were added to one channel of the plate and the chromatograms developed with the organic phase of ethyl acetate :hexane: acetic acid:water (54:25:12:60, by volume). The recovery of added radioactive label was determined to be 94 ± 3%. In experiments in which the amount of unreacted endoperoxide remaining was monitored, in addition to products formed, and in experiments employing time course analysis, the products were extracted with ether :methanol: 0.1 N HC1 (6:1:0.38, vol/vol/vol) by a procedure similar to that described above, and the organic phase was applied to a cold (0°C) silica gel plate. The plate was then developed at room temperature in the chromatographic solvent system described above. With this procedure, relatively little degradation (less than 13%) of unreacted endoperoxide occurred during the assay. The remaining, unreacted endoperoxide migrated in a region slightly less polar thanPGA 2 * Prostaglandin standards were visualized either by spraying the TLC plates with an ethanolic solution of phosphomolybdic acid (10%, wt/vol) and brief heating to 100°C, or by exposure to I2 vapor. The radiolabeled products were localized by radiochromatogram scanning (Packard, model .2301) and were quantified either by integration of peak areas or by scraping the TLC plate and liquid scintillation counting. The quantity of product formed (in pmol) then was calculated, using the specific activity of [l-^CJ-PGHs and the appropriate molecular weight.
Prostaglandin Synthetase Assay
Microsomal preparations were diluted with the Tris-HCl buffer containing 5 mM tryptophan and 2 fxM hemoglobin (final concentration) and pre-incubated for 6 minutes at 37°C Meanwhile, an ethanolic solution of [l-14 C]-arachidonic acid (New England Nuclear), equivalent to 10 \ano\ was pipetted into Eppendorf centrifuge tubes (on ice) and evaporated to dryness under a stream of nitrogen. The arachidonic acid was solubilized by the addition of 100 DIM Tris-HCl buffer, pH 8.2 (50 /d), within 1 minute of initiating the reaction. Aliquots of the microsomal suspension (100 ^1 volume containing 100 fx% protein) then were added to the tubes containing substrate and incubated in a 37 °C water bath for 15 minutes. The reactions were terminated by the addition of 400 yl of ethyl acetate:methanol: 0.2 M citric acid (15:2:1, vol/vol/vol), with rapid mixing of the contents, centrifugation at 12,800 g for 30 seconds to separate the layers, and freezing the aqueous layer in dry-ice/acetone. The organic layers were removed, applied to silica gel plates (Analtech, GHL) at room temperature, along with authentic PG standards, and the chromatograms developed in the organic phase of ethyl acetate: hexane: acetic acid: water (58:26:12:60, by volume). Products were localized by radiochromatogram scanning and comparison with authentic standards followed by quantification by scraping the appropriate zones on the plates and utilization of liquid scintillation techniques. * Proof that tiia product migrating in the region slightly less polar than PGA, was unreacted PGH, was determined by several approaches.
(1) Following development of the chromatogram, the silica gel in the region corresponding to "PGH," was removed from the plate, radioUbel eluted with methanoL and rechrornatographed with authentic standards, A mixture of products co-migrating with PGFi,, PGEx, and PGD, was obtained. (2) After the organic extraction mixture was spotted on the TLC pUte, th« plate was incubated at room temperature for 30 minutes prior to development in the solvent system described above. No radioactivity was detected in the "PGH," region and a greater proportion of the radioactivity co-migrated with PGF^, PGE,, and PGDi. (3) Synthetic PGH, used as substrate in the experiments co-migrated with the "PGH," remaining after incubations with tissue protein and buffer. VOL. 49, No. 5, NOVEMBER 1981 
Materials
Prostaglandin standards were kindly supplied by Dr. John Pike of the Upjohn Co., Kalamazoo, Michigan. [l-I4 C]-Arachidonic acid was obtained from New England Nuclear, glutathione (reduced and oxidized forms) from Sigma Chemical Co., N-ethylmaleimide from Aldrich Chemicals, dithiothreitol, hemiglobin, tryptophan, and bovine serum albumin from Calbiochem-Behring, and 2-mercaptoethanol from Eastman.
Results
Utilization of Endoperoxide Substrate
Initial experiments characterized the capacity of the various myocardial preparations to utilize PGH2 to form prostaglandins. It has been well documented that various factors (see Discussion) can affect the pattern of PGH 2 breakdown. To demonstrate enzymatic formation of a prostaglandin from PGH 2 , a number of criteria were established: the enzymatic formation of the prostaglandin should (1) be destroyed by boiling, (2) be a saturable process, and (3) occur more rapidly and reach a greater maximal concentration than control incubations. The stable hydrolytic product of prostacyclin, 6keto-PGF ]a , is not formed from PGH 2 by non-enzymatic processes. However, metabolism of 6-keto-PGFi a will lower the apparent concentration of prostacyclin formed because of a different location of these products on the thin layer plate. The possibility of a 15-hydroxydehydrogenase that could form 6,15-diketo PGF la and of a A 13 -reductase that could form I3,14-dihydro-6,15-diketo PGF U was eliminated by two procedures: (1) no evidence for compounds co-migrating with authentic 6-keto-PGFu and/or with 13,14-dihydro-6-keto-PGFi,, was observed with any of the myocardial preparations and (2) no evidence for a 15-hydroxydehydrogenase or A 13 -reductase activity in homogenates, high speed supernatant, or microsome fractions (assayed at 50-300 ng protein) could be demonstrated. Therefore the appearance of 6-keto-PGFu may be used as an accurate marker of PGI 2 formation. Rigorous proof of enzymatic formation of other prostaglandins, PGE2, PGD 2 , and HHT (12L-hydroxyheptadecatrienoic acid), was more difficult to establish. The criteria outlined above was especially important for these prostaglandin products. It was established that the demonstration of a PGH-E isomerase or PGH-D isomerase should also require specificity for reduced glutathione and inhibition by sulfhydryl-related reagents (Ogino et al., 1977) . If an isomerase activity was indicated by a significant elevation in PGE or PGD formed, further studies were then initiated to characterize the activity further.
The conversion of PGH 2 to 6-keto-PGF la , PGE 2 , and PGD 2 by homogenates prepared from the "myocardium" the coronary artery, vein, microvessels and the isolated myofibrils is given in Figure 3 . Prostacyclin formation (indicated by the amount of 6-keto-PGF lo formed) was greatest in homogenates of the coronary vein, relatively high in the coronary artery and myocardium homogenates, but little could be detected in the homogenates from the coronary microvessel or isolated myofibrils. The presence of PGH-E or PGH-PGD-isomerase activity was tested by the addition of 2 HIM reduced glutathione; no significant enhancement of the formation of either PGE or PGD was observed in any of the five homogenate preparations (data not shown). Both a heat-denatured microvessel homogenate sample (50 fig protein) and a solution containing bovine serum albumin incubated with PGH2 yielded quantities of PGF^, PGE 2 , PGD 2 , arid HHT similar to those generated by the microvessels and myofibril homogenate.
The conversion of PGH 2 to prostaglandins by microsomes prepared from the various components of the bovine heart is summarized in Figure 4 . When standardized with respect to microsomal protein, the coronary vein again exhibited highest prostacyclin synthetase activity, followed by the coronary artery and microvessels. There was little evident dependence of product generation on protein (i.e., enzyme) concentration in the absence of reduced glutathione. Further, addition of glutathione to the incubations with coronary artery, myofibril, or intact heart microsomes did not alter the pattern of PG product formation. In contrast, a large enhance-
PGE,
PGD, The effect of 2 mM reduced glutathione on the pattern of prostaglandin product formation in the coronary vein and microvessels was then further evaluated utilizing six different microvessel preparations and four coronary vein preparations. The addition of GSH to the coronary vein preparations at both protein concentrations resulted in a reduction of 6-keto-PGFi a formation and a significant increase (P < 0.01) in PGE 2 formation (Fig. 5 ). An apparent shunting of substrate from prostacyclin synthetase had resulted due to GSH enhancement of PGH-E isomerase activity. In contrast, although the coronary microvessels also demonstrated a significant elevation in PGE 2 formation (P < 0.005) at both protein concentrations with the addition of GSH, this occurred primarily at the expense of unreacted PGHj and PGD 2 . This difference is probably due to the intrinsically lower prostacyclin synthetase activity in the microvessel microsomes.
We have previously characterized the non-enzymatic formation of PGE2 in the presence of buffer •f It would not be correct to subtract the values for PGF«., PGEi. and PGDi or hydroxy acid* obtained in the control incubations from that determined in experimental tissue samples to obtain the "net" product generated. If an enzyme activity a expressed in a reaction, then the amount of substrate (POHj) available for nonenzyrrutic breakdown is reduced proportionately. It is possible, therefore, to list only the amounts of product generated in the incubation of an experimental t i n i e preparation to compare these values with the control values, considering the latter as upper limits for nonenzymatic breakdown of the substrate.
(46 mM KPO«, ± 2 mM GSH), boiled cerebral microvessel microsomes (±2 mM GSH), and 50 /ig bovine serum albumin under identical assay conditions as those described above (Gerritsen et al., 1980) . We were unable to demonstrate by any experimental manipulations a significant effect of 2 mM GSH on the rate of formation of PGE 2 in the absence of native tissue protein. The issue as to which of the three "control" samples (buffer, albumin, or boiled microsomes) constitutes the most appropriate control for comparison is a pertinent one. Although the percent endoperoxide converted to PGE 2 in buffer at 5 minutes was similar to that observed in coronary microvessels with 2 mM GSH present, buffer alone does not provide a good control system since the presence of protein (either tissue protein, boiled microsomal protein, or bovine serum albumin) results in a reduction of total PGE 2 formed at 5 min, e.g., from -63 pmol in buffer to 36-48 pmol in buffered protein (Gerritsen et aL, 1980) . The best control for comparison with "enzymatic" PGE2 formation is therefore heat-denatured protein or possibly native microsomal protein in the absence of GSH. Included in Figure 5 are the results using 50 |ig of denatured coronary microvessel microsomal protein. It is apparent that no 6-keto-PGFi o formation occurred in denatured protein solutions, and further, no enhancement of PGEj formation (or of any other prostaglandin) was evident with the inclusion of GSH.
The rates of formation of 6-keto-PGFi 0 and PGE? in an incubation of coronary microvessel microsomes containing 2 mM GSH were determined at VOL. 49, No. 5, NOVEMBER 1981 6-k-PGF, a Vein Microvessel 23°C (Fig. 6 ). Formation of 6-keto-PGFi a was virtually complete at the first experimental time point (10 seconds), whereas formation of PGE2 occurred at nearly a constant rate for 1-1.5 minutes, then slowly reached a plateau. The microsomal protein (i.e., enzyme) dependence on the conversion of PGH2 to prostaglandin products was determined with two preparationscoronary artery and coronary microvessel microsomes. At all protein concentrations, the coronary Boiled Control artery preparation converted to a greater proportion of the substrate (PGH 2 ) to 6-keto-PGF, a thar did the coronary microvessels (Fig. 7) . No significant GSH-enhanced PGE formation was observed with the coronary artery microsomes at any of the protein concentrations studied (data not shown). In the coronary microvessel preparation, maxima] GSH-enhanced PGE 2 formation occurred at 50 /x § protein (Fig. 8) ; however, GSH-enhancement ol PGE2 formation was evident at a protein concentration as low as 10 jug. The enhanced formation ol PGE 2 by GSH was not at the expense of prostacyclin formation (Figs. 5, 8) but rather reduced the amount of unreacted endoperoxide. Enhancement of PGE 2 formation was specific for reduced glutathione; other thiols (dithiothreitol, 2mercaptoethanol or oxidized glutathione) were without effect (data not shown). Irreversible inhibition of PGH-E isomerase activity was achieved by pre-incubation of the microsomes with 1 mM Nethylmaleimide; addition of an excess of GSH added during the incubation failed to restore the glutathione dependence. Formation of 6-keto-PGF ]o was enhanced greatly by addition of two thiols to the incubation reaction-dithiothreitol (increased 200%, 10 to 32 pmol), and 2-mercaptoethanol (increased 180%, 10 to 28 pmol). These thiols had no effect of PGE 2 formation.
The competition between PGH-E isomerase activity and prostacyclin synthetase for exogenous radiolabeled PGH2 was studied using microvessel microsomes. One problem encountered with this type of experiment evaluating two competing enzymatic reactions for the same substrate is the complication introduced by non-enzymatic degradation of the substrate. For this reason, experiments were performed under conditions of (1) optimal PGE 2 formation, i.e., 50 ng protein, 2 mM GSH; (2) at a time while formation of PGE2 was still linear, i.e., at t = 30 sec, 23°C; and (3) with minimal nonenzymatic degradation of PGH 2 (13-18% total PGH2 breakdown, with the major PGH2 degradation product co-migrating with PGD2). Extensive kinetic studies indicated that maximal formation of 6-keto-PGF la was attained within 10 seconds; thus, at the times used in this experiment, non-linear reaction conditions existed for prostacyclin synthetase. Prostacyclin synthetase activity in microvessel microsomes appeared to saturate at -10 /AM PGH 2 (Fig. 9 ). Below this substrate concentration the two enzymatic reactions would exhibit maximal competition and the substrate dependence of PGE2 formation was therefore complicated. At substrate concentrations greater than 10 fiM PGH 2 , PGE2 formation was approximately linear and the isom-erase saturated at concentrations exceeding 100 flM.
High speed supernatants prepared from the whole heart, coronary microvessels, or isolated myofibrils exhibited little prostacyclin synthetase activity (Fig. 10) . The relatively high 6-keto-PGFi o formation obtained with the coronary artery and coronary vein high speed supernatant most likely reflects microsomal contamination of the preparations, since prostacyclin synthetase has been shown to be a microsomal enzyme (Salmon et al., 1978) . Addition of reduced glutathione did not specifically enhance either 6-keto-PGFi. or PGE2 formation by any of the preparations; however, PGD 2 formation was significantly elevated in the coronary artery and coronary vein high speed supernatant fractions. The lack of increase in PGF^ or PGE 2 indicates that glutathione-S-transferase activity was probably not responsible for enhanced PGD 2 formation (Christ-Hazelhof et al., 1976) . We and other members of this laboratory have noted previously the presence of a PGD isomerase activity in soluble fractions prepared from other vascular tissues (bovine aorta, rat arteries, and veins) (Skidgel and Printz, 1980; Parks and Printz, 1980) . No evidence for GSH-enhanced PGD 2 formation was observed in the high speed supernatants of the coronary microvessels.
Prostaglandin Synthetase Activity
Arachidonic acid utilization (i.e., prostaglandin product formation) in all the myocardial preparations was low (<4%) ( Table 1 ). The coronary artery microsomes exhibited the greatest activity, followed by the coronary vein and coronary microvessels; "myocardium" and myofibril fractions exhibited virtually no conversion. The predominant conversion product of the coronary artery and vein was 6keto-PGFi,, (approximately two-thirds of the total prostaglandins), with minor formation of PGF^ and 1000 • 20 40 60 80 100
The effects of varying substrate (PGH-i) concentration (from 2-100 yM) on 6-keto-PGF, a (A) and PGE\ (OJ formation by coronary microvessel microsomes. VOL. 49, No. 5, NOVEMBER 1981 6kPGF,« PGE 2 . The coronary microvessels formed similar proportions of three products: 6-keto-PGFi a , PGFâ nd PGE 2 .
Discussion
The development of methodology for the isolation of metabolically active microvasculature from a given tissue provides a new approach for the investigation of the resistance elements of the vasculature. In the past, various laboratories including our own have reported on the purification of microvessels (defined as those vessels less than 300 ^un in diameter) from "soft" tissues, i.e., cerebral cortex and retina Gerritsen et al., 1980) . These microvessel preparations have been shown to contain arterioles, capillaries, and venules, as demonstrated both morphologically and bio-chemically Lai et al., 1975) . By adaptation of methods used previously to isolate cerebral and retinal microvessels, we were able to develop an approach for the mechanical isolation of coronary microvessels. The resulting preparations were virtually free of myocytes and contained a high proportion of vessels less than 60 jum in diameter. A significant difference in the appearance of this microvessel preparation with that of the cerebral cortex or retina was the presence of numerous collagen fibers. This is not a surprising finding, however, as the microvasculature of the heart in situ has been shown by electron microscopy to contain many collagen bundles in regions surrounding the capillaries, arterioles, and venules (Sommer and Johnson, 1979) . Although our procedure requires a fairly long period of time (2-3 hours) for Values are expressed as the percent conversion of [l-!1 C]-arachidonic acid to product (mean ± SEM). " This value may also include minor formation of 6,15-diketo PGFi. (which co-migrates with PGFj. in this solvent system), a product that could b« formed from PGGj by prostacyclin synthetaae. the isolation of the coronary microvessels, the preparations appeared to remain metabolically active as evidenced by linear evolution of U C-CO 2 from glutamate or glucose substrates.
A previous report has described a procedure for the isolation and characterization of endothelial cells from the coronary microvasculature of the rabbit heart (Simonescu and Simonescu, 1978) . The technique involved the combination of homogenization and cell isolation utilizing enzymic digestion with collagenase, and yielded a preparation of isolated endothelial cells suitable for cell suspension or cell culture studies. The methods we detail in this paper result in a preparation of coronary microvascular elements (arteriole, capillary, venule) untreated by proteolytic enzymes and suitable for many studies involving all elements of the coronary microvasculature free of the muscular components of the heart. As our method yields four major components of the bovine myocardium, i.e., myofibrils, major vessels (artery, vein), and microvessels, this permitted a more specific localization of the prostaglandin biosynthetic machinery. The whole heart preparation actually represents a composite of the four isolated preparations, as well as the endocardium. Separation of myofibrils from the microvascular elements further facilitated evaluation of the relative contribution of the myocardial cells and of the coronary vasculature to the total prostaglandin biosynthesis in the bovine heart.
The radiometric microassay used in this study readily identifies both prostacyclin and thromboxane synthetase by the formation of the stable products 6-keto-PGFi a and TXB 2 (Skidgel and Printz, 1978) . In the absence of active enzymes, these products are not formed. No thromboxane synthetase activity could be identified, as no evidence for TXB2 formation by any of the heart fractions was observed in our study. It was more difficult to determine rigorously that the other products of PGH 2 metabolism were generated enzymatically. Prostaglandin endoperoxide will degrade non-enzymatically to form a mixture of PGF 2o , PGE*, PGD 2 , and hydroxyacid. In addition, serum albumin has been reported to enhance PGD 2 formation through a process unaffected by reduced glutathione (Hamberg and Fredholme, 1976) . Various organic sulfur compounds also can influence PGH2 breakdown (Raz et aL, 1977a) . It is important to note, however, that specific enhancement of PGE2 formation by reduced glutathione has never been reported with any non-specific protein or buffer interaction with PGH 2 . Thus glutathione dependence was one important element for the demonstration of PGH-E isomerase activity. Glutathione-S-transferases, a froup of enzymes found in the soluble fraction of various cells, were found to enhance primarily PGF 2o and PGD 2 formation, although one gtudy did show increased production of PGF 2a , PGE2, and PGD 2 (Christ-Hazelhof et al., 1976) .
We reported recently on the presence of PGH-E isomerase present in bovine cerebral microvessels and also observed this activity in bovine retinal microvessels (Gerritsen et al., 1980; Gerritsen and Printz, 1981) . A similar activity was found in the coronary microvessels as discussed above. The coronary micro vessel PGH-E isomerase appears to be similar to other PGH-E isomerases, i.e., the bovine seminal vesicle (Ogino et al., 1977) and bovine cerebral microvessel (Gerritsen et aL, 1980) enzymes, in the specificity for reduced glutathione, the inhibition by Af-ethylmaleimide, saturation of the enzyme at high substrate (>100 /IM) concentrations, and its microsomal localization. With increasing amounts of coronary microvessel protein, an increased formation of PGE 2 was observed in the presence of GSH, with maximal PGE 2 formation occurring at 50 fig protein. The detectable GSH-enhancement of PGE forming activity in the coronary vein microsomes indicated that a similar isomerase activity was present in the coronary vein and was able to compete for substrate with prostacyclin synthetase; i.e., an increase in PGE 2 was accompanied by a decrease in 6-keto-PGFi a formation. However, the amount of PGE 2 formed was less than that formed by the coronary microvessel microsome preparation. Under the experimental conditions employed in this study, the coronary vein converted a greater proportion of PGH 2 to 6-keto-PGFi Q than did the coronary artery at similar microsomal protein concentrations.
The glutathione-enhanced PGD 2 formation in the high speed supernatant of the coronary artery and vein indicates that a PGH-PGD isomerase may be present in these tissues. Parks and Printz (1980) have previously described the nature of this activity in vascular tissues (including the bovine aorta). This cytosolic activity was destroyed by boiling or incubation with sulfhydryl-directed reagents (Nethylmaleimide, p-hydroxymercuribenzoate), and was specific for reduced glutathione. Nonetheless, it remains to be demonstrated if PGD 2 formation and release actually occurs in vascular tissues. An observed apparent increase in 6-keto-PGFi a formation in the presence of dithiothreitol and 2-mercaptoethanol may reflect a protective effect, namely, a reduced inactivation of the prostacyclin synthetase. Glutathione did not appear to affect directly the synthesis of 6-keto-PGFi Q by the microvessels.
The observed prostaglandin synthetase activity of the components of the myocardium was low, with both the coronary artery and vein the most active. This is not a novel finding, as many investigators have observed low conversion of arachidonic acid to prostaglandin products in a variety of vascular preparations and species. The lower cyclooxygenase activity of the microvessels compared to the major vessels may indicate a real difference in the activity of the enzyme in the macro-and microvasculature. VOL. 49, No. 5, NOVEMBER 198 Alternatively, the prolonged preparation time and the homogenization procedure for the microvessels may explain this apparent low enzymatic activity. The lack of any significant cyclooxygenase activity in the isolated myocytes and intact heart preparation and the absence of prostaglandin endoperoxide-metabolizing activities in the myofibril fractions indicate that the myocytes of the heart possess little, if any, ability to synthesize prostaglandins. These two fractions could be obtained within minutes after initiation of the preparation, and therefore it is unlikely that loss of activity by experimental manipulation could explain the low prostaglandin synthesis by these preparations. Other authors (Hsueh and Needleman, 1978) have also noted that myocardial cells exhibit much less prostaglandin synthetic activity when compared to coronary vasculatirre although an early report by Lamas and Cohen (1973) described a myocardial prostaglandin synthetase activity in microsomes prepared from intact heart. However, our results indicate that the activity these authors described was probably due to vascular elements present in their preparation.
Our findings clearly suggest that the coronary vasculature is responsible for the majority of prostaglandins released by the myocardium. Considered together, the macro-and microvasculature contained several prostaglandin endoperoxide-metabolizing enzymes: prostacyclin synthetase, PGH-PGE isomerase, and PGH-PGD isomerase. The presence of different prostaglandin endoperoxidemetabolizing enzymes could reflect localization to a given region (artery, vein, arteriole, capillary, venule) or cell type (endothelial cell, vascular smooth muscle cell, pericyte, fibroblast). A number of reports (Moncada et al., 1977; Weksler et al., 1977) indicate that the endothelium may be a major source of prostacyclin formed by blood vessel walls. However, we and others (Parks and Printz, 1978; Silberbauer et al., 1978) have shown that the smooth muscle layer of vessel walls is capable of forming significant amounts of PGI2. The PGH-PGE isomerase activity observed in the coronary microvessels appears to be localized in this fraction of the coronary vasculature, although some activity may be present in the coronary vein. This finding indicates that PGE? may exert a local role in the function of the resistance elements of the coronary circulation. PGE2 has been shown to affect dilation of arterioles and venulea (Messina et al., 1974) , erythrocyte deformability (Allen, 1974) , norepinephrine release (Hedquist, 1974) , and action of norepinephrine on vascular smooth muscle (Altura and Altura, 1976) , and the action of various hormones on microcirculatory function (Messina et al., 1976 )-all functions associated with the microvasculature. The nature and quantity of prostglandins released from the myocardium in situ is probably therefore a function of the site (artery, vein, microvessel) of synthesis and, in the microvasculature, the relative ratios of enzyme to substrate.
